Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: A replacement for 14-day susceptibility testing?

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1705-1707

  Hanson, Kimberly E ^a   Slechta, E Susan ^b   Muir, Haleina ^c   Barker, Adam P ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MACROLIDE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; DNA POLYMORPHISM; ERM GENE; GENE SEQUENCE; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; NONHUMAN; PRIORITY JOURNAL; DNA SEQUENCE; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MYCOBACTERIUM; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; POLYMERASE CHAIN REACTION; PROCEDURES;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84899516131     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03464-13     Document Type: Article

References (19)

1. Petrini B. 2006. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS 114:319-328. http://dx.doi.org/10.1111/j.1600-0463. 2006.apm-390.x.
2. Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, Reacher M, Haworth CS, Curran MD, Harris SR, Peacock SJ, Parkhill J, Floto RA. 2013. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 381:1551-1560. http://dx.doi.org/10.1016/S0140-6736 (13) 60632-7.
3. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416. http://dx.doi.org/10.1164/rccm. 200604-571ST.
4. Wallace RJ, JR, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, Böttger EC. 1996. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob. Agents Chemother. 40:1676-1681.
5. Nash KA, Brown-Elliott BA, Wallace RJ, JR. 2009. A novel gene, erm (41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob. Agents Chemother. 53:1367-1376. http://dx.doi.org/10.1128/AAC.01275-08.
6. Bastian S, Veziris N, Roux AL, Brossier F, Gaillard JL, Jarlier V, Cambau E. 2011. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm (41) and rrl sequencing. Antimicrob. Agents Chemother. 55:775-781. http://dx.doi.org/10.1128/AAC.00861-10.
7. Kim HY, Kim BJ, Kook Y, Yun YJ, Shin JH, Kim BJ, Kook YH. 2010. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol. Immunol. 54:347-353. http://dx.doi.org/10.1111/j.1348-0421.2010.00221.x.
8. Brown BA, Wallace RJ, Onyi GO, De Rosas V, Wallace RJ. 1992. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob. Agents Chemother. 36:180-184. http://dx.doi.org/10.1128/AAC.36.1.180.
9. Clinical Laboratory Standards Institute. 2011. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard-2nd ed. CLSI M24-A2. Clinical Laboratory Standards Institute, Wayne, PA.
10. Clinical Laboratory Standards Institute. 2008. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. CLSI MM18-A. Clinical Laboratory Standards Institute, Wayne, PA.
11. Cloud JL, Hoggan K, Belousov E, Cohen S, Brown-Elliott BA, Mann L, Wilson R, Aldous W, Wallace RJ, JR, Woods GL. 2005. Use of the MGB Eclipse system and SmartCycler PCR for differentiation of Mycobacterium chelonae and M. abscessus. J. Clin. Microbiol. 43:4205-4207. http://dx.doi.org/10.1128/JCM.43.8.4205-4207. 2005.
12. Neal H, Cloud JL, Pounder JI, Page SR, Woods GL. 2005. Sequence variant for internal transcribed spacer region of Mycobacterium abscessus. J. Clin. Microbiol. 43:6214. http://dx.doi.org/10.1128/JCM.43.12.6214.2005.
13. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
14. Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Shin SJ, Huitt GA, Daley CL, Kwon OJ. 2011. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am. J. Respir. Crit. Care Med. 183:405-410. http://dx.doi.org/10.1164/rccm.201003-0395OC.
15. Macheras E, Roux AL, Bastian S, Leao SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rusch-Gerdes S, Pfyffer G, Bodmer T, Cambau E, Gaillard JL, Heym B. 2011. Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. J. Clin. Microbiol. 49:491-499. http://dx.doi.org/10.1128/JCM.01274-10.
16. Macheras E, Roux AL, Ripoll F, Sivadon-Tardy V, Gutierrez C, Gaillard JL, Heym B. 2009. Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. J. Clin. Microbiol. 47:2596-2600. http://dx.doi.org/10.1128/JCM.00037-09.
17. Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, Conlan S, McNulty S, Brown-Elliott BA, Wallace RJ, JR, Olivier KN, Holland SM, Sampaio EP. 2009. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J. Clin. Microbiol. 47:1985-1995. http://dx.doi.org/10.1128/JCM.01688-08.
18. Shallom SJ, Gardina PJ, Myers TG, Sebastian Y, Conville P, Calhoun LB, Tettelin H, Olivier KN, Uzel G, Sampaio EP, Holland SM, Zelazny AM. 2013. New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessusgroup and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance. J. Clin. Microbiol. 51:2943-2949. http://dx.doi.org/10.1128/JCM.01132-13.
19. Teng SH, Chen CM, Lee MR, Lee TF, Chien KY, Teng LJ, Hsueh PR. 2013. Matrix-assisted laser desorption ionization-time of flight mass spectrometry can accurately differentiate between Mycobacterium masilliense (M. abscessus subspecies bolletti) and M. abscessus (sensu stricto). J. Clin. Microbiol. 51:3113-3116. http://dx.doi.org/10.1128/JCM.01239-13.